Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes

Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Duhl, A. J., Paidas, M. J., Ural, S. H., Branch, W., Casele, H., Cox-Gill, J., Hamersley, S. L., Hyers, T. M., Katz, V., Kuhlmann, R., Nutescu, E. A., Thorp, J. A., Zehnder, J. L. 2007; 197 (5)

Abstract

Venous thromboembolism and adverse pregnancy outcomes are potential complications of pregnancy. Numerous studies have evaluated both the risk factors for and the prevention and management of these outcomes in pregnant patients. This consensus group was convened to provide concise recommendations, based on the currently available literature, regarding the use of antithrombotic therapy in pregnant patients at risk for venous thromboembolic events and adverse pregnancy outcomes.

View details for DOI 10.1016/j.ajog.2007.04.022

View details for Web of Science ID 000250915500004

View details for PubMedID 17980177